Click here to download Advance Program as a pdf.
(updated July 1, 2014)

 

Saturday, July 26, 2014

Sunday, July 27, 2014

Monday, July 28, 2014

 

 

MONDAY, JULY 28, 2013

_________________________________________________________________________________________

08:30 – 11:00                                                                                                            Hall A
_________________________________________________________________________________________

PL17    Plenary Session
              DIET, LIFESTYLE AND CVD PREVENTION – NEW ORIGINS

IS THE DASH DIET THE OPTIMAL DIET FOR HEART FAILURE PATIENTS? (Invited Lecture)
M.A. Silver, Advocate Christ Medical Center, University of Illinois. IL, USA

MEDITERRANEAN DIET AND SECONDARY PREVENTION OF CVD (Invited Lecture)
D.B. Panagiotakos, Harokopio University, Athens, Greece

LOOKING BACK ON THE LOOK AHEAD TRIAL (Invited Lecture)
E. Barrett-Connor, University of California San Diego, La Jolla, CA, USA

SATURATED FAT INTAKE AND THE GENESIS OF CORONARY ARTERY DISEASE – WHERE’S THE EVIDENCE? (Invited Lecture)
S. Vallurupalli, J.L. Mehta
University of Arkansas for Medical Sciences, Little Rock, AR, USA

INTEGRATING NUTRITION EDUCATION INTO THE CARDIOVASCULAR CURRICULUM CHANGES MEDICAL STUDENT EATING HABITS (Invited Lecture)
R. Zelis, E. Vargas
Pennsylvania State University, Hershey Medical Center, Hershey, PA, USA

DO VITAMIN AND MINERAL SUPPLEMENTS HAVE A ROLE IN CARDIOVASCULAR DISEASE PREVENTION? (Invited Lecture)
H.D. Sesso, Brigham and Women's Hospital, Boston, MA, USA

ALTERNATE HEALTHY EATING INDEX, MEDITERRANEAN AND DASH DIETARY PATTERNS AND RISK OF DEATH IN THE PHYSICIAN'S HEALTH STUDY (Invited Lecture)
L. Djousse, A. Petrone, J.M. Gaziano
Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

RACIAL DIFFERENCES IN VITAMIN D/PARATHYROID HORMONE ENDOCRINE SYSTEM AND CARDIOVASCULAR DISEASE (Invited Lecture)
Y. Song, Indiana University, Indianapolis, IN, USA

DIETARY FATTY ACID COMPOSITION AS A RISK FACTOR FOR CARDIOMETABOLIC DISORDERS: BEYOND THE CALORIES (Invited Lecture)
L. Wang, Brigham and Women's Hospital, Boston, MA, USA

THE ROLE OF EXERCISE AND REHABILITATION FOR HEART FAILURE PATIENTS(Invited Lecture)
C. Chrysohoou, Hippokration Hospital,University of Athens, Greece

11:00    COFFEE BREAK, VISIT POSTERS AND EXHIBITION

 

MONDAY, JULY 28, 2104

_________________________________________________________________________________________

08:30 – 11:00                                                                                                            Hall B
_________________________________________________________________________________________

PL18    Plenary Session
              ADVANCES IN THE TREATMENT AND MANAGEMENT OF HEART FAILURE

THE MANAGEMENT OF PATIENTS WITH ADVANCED HEART FAILURE (Invited Lecture)
V.H. Pitzalis, East Carolina University, The Brody School of Medicine, Greenville, NC, USA

CAN WE PREVENT HEART FAILURE READMISSIONS? (Invited Lecture)
P.A. Heidenreich, Stanford University, Palo Alto, CA, USA

ROLE OF THE "PERIPHERY" IN HEART FAILURE AND PRESERVED EJECTION FRACTION (Invited Lecture)
J.A. Chirinos, University of Pennsylvania School of Medicine, Philadelphia, PA, USA

CARDIORENAL SYNDROME: NOT AS STRAIGHT FORWARD AS WE USED TO THINK (Invited Lecture)
A. Kazory, University of Florida, Gainesville, FL, USA

NEW TECHNOLOGIES TO IMPROVE CRT OUTCOME (Invited Lecture)
K. Seidl, Klinikum Ingolstadt, Germany

COLCHICINE AND NEW MANAGEMENT STRATEGIES FOR ACUTE AND RECURRENT PERICARDITIS (Invited Lecture)
M. Imazio, Maria Vittoria Hospital, Torino, Italy

SKELETAL MUSCLE HYPERTROPHY INDUCED BY NOVEL KAATSU REHABILITATION AND PREVENTION OF SARCOPENIA (Invited Lecture)
T. Nakajima, T. Yasuda, S. Koide, Y. Sato, T. Morita, T. Tomaru, Y. Kano
University of Tokyo, Tokyo, Japan

PERICARDIAL INVOLVEMENT FREQUENTLY COMPLICATING PULMONARY AND/OR SYSTEMIC SARCOID GRANULOMATOSIS.A LIFE-LONG, MULTI STAGE DISEASE, PERIODICAL STUDY IN 278 BIOPSY –PROVEN SARCOIDOSIS PATIENTS (Invited Lecture)
I. Angomachalelis, K. George, N. Angomachalelis
G. Papanikolaou General Hosptal, Thessaloniki, Greece

IMATINIB: A NOVEL CANDIDATE FOR TREATMENT OF PERMEABILITY EDEMA (Invited Lecture)
G.P. van Nieuw Amerongen, VU University Medical Center, Amsterdam, The Netherlands

11:00    COFFEE BREAK, VISIT POSTERS AND EXHIBITION

 

MONDAY, JULY 28, 2014
_________________________________________________________________________________________

08:30 – 11:00                                                                                                            Hall C
_________________________________________________________________________________________

S33      Session
            THE RELEVANCE OF GENETICS IN PROVIDING UNDERSTANDING AND TREATMENT FOR CARDIOVASCULAR DISEASE

PHARMACOGENETICS-GUIDED INDIVIDUAL WARFARIN DOSING IN A CARDIOLOGY CLINIC – A PERSPECTIVE OBSERVATORY STUDY
W.Q. Fan, Y. Wu, B. Khalighi, A. Mirabbasi, R. Thachil, E.J. Mascarenhas, K. Khalighi
Easton Hospital, Drexel University, Easton, PA, USA

A MICRO-RNA-410 REGULATED LIPOPROTEIN LIPASE POLYMORPHISM IS ASSOCIATED WITH TRIGLYCERIDES AND STROKE INCIDENCE
D. Corella, O. Coltell, J.V. Sorli, R. Estruch, M. Fito, F. Aros, E. Ros, J. Lapetra, G.T. Saez, J.M. Ordovas
Instituto de Salud Carlos III, Madrid, Spain

ATF3 PROTECT AGAINST PRESSURE OVERLOAD HEART FAILURE VIA BECLIN-1 PATHWAY
C.F. Cheng, S.F. Li, H. Lin
Tzu Chi General Hospital, Hualien, Taiwan

RAPID UP-REGULATION AND CLEARANCE OF DISTINCT CIRCULATING MICRORNAS AFTER PROLONGED AEROBIC EXERCISE
A.L. Baggish, J. Park, P-K.Min, S. Isaacs, B.A. Parker, P.D. Thompson, C. Troyanos,
P. D’Hemecourt, S. Dyer, M. Thiel, A. Hale, S.Y. Chan
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

RANOLAZINE PREVENTS TRASTUZUMAB-CARDIOTOXICITY IN EXPERIMENTAL MODELS
N. Maurea, C. Coppola, G. Piscopo, D. Rea, C. Maurea, F. Galletta, E. Esposito,
I. Capasso, P. Maiolino, C. Arra
National Cancer Institute Pascale Foundation IRCCS, Naples, Italy

VARIATION IN THE MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 6 GENE, DAIRY INTAKE AND CARDIOVASCULAR RISK
O. Coltell, C. Ortega-Azorin, M.A. Martinez-Gonzalez, J. Salas-Salvado,
L. Serra-Majem, E. Gomez-Gracia, V. Ruiz-Gutierrez, M. Fiol, X. Pinto, D. Corella
Instituto de Salud Carlos III, Madrid, Spain

GENE ELECTRO TRANSFER OF PVEGF INDUCES ANGIOGENESIS AND IMPROVES CARDIAC FUNCTION IN A PORCINE ISCHEMIA MODEL
B. Hargrave, R. Strange, Jr., C. Lundberg, N. Burcus, A. Bulysheva, R. Heller
Old Dominion University, Norfolk, VA, USA

THE FAMILY HISTORY AND GENETIC RISK DISCONNECT IN WOMEN
B.T. Costello, R. Doukky, G.P. Lundberg, L.T. Braun, A.S. Volgman
Rush University Medical Center, Chicago, Illinois, USA

REPETITIVE APPLICATION OF RESTRICTION OF MUSCLE BLOOD FLOW
ENHANCES MTOR SIGNALING PATHWAYS IN A RAT MODEL 
T. Nakajima, T. Yasuda, S. Koide, Y. Sato, T. Tomaru, Y. Kano
University of Electro-Communications, Tokyo, Japan

 

MONDAY, JULY 28, 2014
_________________________________________________________________________________________

11:15 – 13:45                                                                                                            Hall A
_________________________________________________________________________________________

PL19    Plenary Session
CURRENT CONCEPTS AND FUTURE DIRECTIONS IN ISCHEMIC HEART DISEASE AND ACUTE CORONARY SYNDROME

OLD AND EMERGING OPTIONS FOR TREATMENT OF REFRACTORY ANGINA: A CRITICAL APPRAISAL (Invited Lecture)
U. Thadani, University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, OK, USA

MANAGEMENT OF STABLE ISCHEMIC HEART DISEASE: OVERVIEW OF RECENT GUIDELINES (Invited Lecture)
J.M. Gardin, Hackensack University Medical Center, NJ, USA

IN-VIVO RISK STRATIFICATION OF INDIVIDUAL CORONARY ARTERY PLAQUES: EVOLVING PARADIGM FOR PREEMPTIVE MANAGEMENT OF PATIENTS WITH CAD (Invited Lecture)
P.H. Stone, Brigham & Women's Hospital, Boston, MA, USA

FRACTIONAL FLOW RESERVE (FFR) AT 2014- WHERE ARE WE AND WHERE IS IT GOING (Invited Lecture)
E. Kaluski, University Hospital, Newark, NJ, USA

IS ISCHEMIA UNIVERSAL IN A CHRONIC TOTAL OCCLUSION? (Invited Lecture)
R. Sachdeva, North Fulton Hospital, Roswell, GA, USA

OPTIMAL DURATION OF DUAL ANTIPLATELET THERAPY AFTER DES IMPLANTATION: EXCELLENT TRIAL AND FUTURE PERSPECTIVES (Invited Lecture)
H-C. Gwon, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

DUAL UTILIZATION OF EXERCISE ECHOCARDIOGRAMS AND MYOCARDIAL PERFUSION IN ASSESSING ISCHEMIA IN A CARDIOLOGY PRACTICE (Invited Lecture)
Y. Charuzi, R.W. Gao, J. Mirocha, Cedars Sinai Heart Institute, Los Angeles, CA, USA

ATYPICAL AND UNUSUAL CLINICAL PRESENTATIONS OF PATIENTS WITH ISCHEMIC HEART DISEASE (Invited Lecture)
H.K. Reddy, R. Komatireddy, R.K. Sharma
St. Louis University Medical School, St. Louis, Missouri, USA

STABLE ISCHEMIC HEART DISEASE: EVOLVING CONCEPTS AND THE ROLE OF ISCHEMIA
M.S. Sidhu, Albany Medical College, Albany, NY, USA

SHOULD DUAL ANTI-PLATELET THERAPY FOR CORONARY ARTERY DISEASE BE MORE OR LESS THAN 12 MONTHS? : A META-ANALYSIS
D. Garcia, M. Ansari, C. Martinez, C. Alfonso, A. Benjo, M. Cohen, E. De Marchena
University of Miami/Jackson Memorial Hospital, Miami, FL, USA

CT FLOW METRICS BASED ON CONTRAST OPACIFICATION
F.J. Rybicki, D.M. Mitsouras
Applied Imaging Science Lab, Brigham and Women's Hospital, Boston, MA, USA

 

MONDAY, JULY 28, 2104

_________________________________________________________________________________________

11:15 – 13:45                                                                                                            Hall B
_________________________________________________________________________________________

PL20    Plenary Session
              OBESITY, DIABETES AND CVD

THE MACROPHAGE A2B ADENOSINE RECEPTOR REGULATES OBESITY-INDUCED TISSUE INSULIN SENSITIVITY (Invited Lecture)
K. Ravid, H. Johnston-Cox, A. Eisenstein, M. Koupenova-Zamor
Boston University School of Medicine, Boston, MA, USA

METABOLIC SYNDROME CRITERIA: CAUSE VERSUS EFFECT OF CARDIOMETABOLIC DISEASE
T.B. Levine, Drexel University College of Medicine, Philadelphia, PA, USA

MITOCHONDRIAL DYSFUNCTION AND DIABETIC HEART DISEASE (Invited Lecture)
S. Kobayashi, Y. Huang, Q. Liang
New York Institute of Technology, Old Westbury, NY, USA 

BENEFIT AND RISKS OF ANTIDIABETIC TREATMENT IN PATIENTS WITH CORONARY ARTERY DISEASE AND HEART FAILURE (Invited Lecture)
C.H. Saely, VIVIT Institute, Academic Teaching Hospital, Feldkirch, Austria

SERENDIPITY IN MEDICINE; DOES CHANCE TRULY FAVOR THE PREPARED MIND? (Invited Lecture)
R.W.W. Biederman, Carnegie Mellon University, Allegheny General Hospital, Pittsburgh, PA, USA

HIGH CARDIOVASCULAR RISK IN NON-ALCOHOLIC FATTY LIVER DISEASE: A POSSIBLE ROLE FOR INCREASED OXIDATIVE STRESS? 
F. Angelico, M. Del Ben, L. Polimeni, F. Baratta, D. Pastori, R. Carnevali, S. Bartimoccia, F. Violi
Sapienza University, Rome, Italy

IMPACT OF METABOLIC SYNDROME ON SUBCLINICAL ATHEROSCLEROSIS IN ASYMPTOMATIC INDIVIDUALS
S.M. Jung, G.M. Park, C.J. Kim, J.S. Cho, M.W. Park, S.H. Her, S.W. Lee
Daejeon St. Mary's Hospital, the Catholic University of Korea, Daejeon, Korea

 

 

MONDAY, JULY 28, 2104

_________________________________________________________________________________________

11:15 – 13:45                                                                                                            Hall C
_________________________________________________________________________________________

S34  Session    

DISEASE PATHWAYS AND NEW TREATMENT STRATEGIES IN HEART FAILURE AND CARDIOMYOPATHIES

TREATING RAPID ATRIAL FIBRILLATION IN DECOMPENSATED HEART FAILURE: METOPROLOL IS SUPERIOR TO DILTIAZEM
F. Katchi, S. Nagabandi, J. Shuster, E. Novak, S. Joseph
Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA

PREDICTORS OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
A. Kumar, A.K. Saluja, A. Khan, D. Gandhi, M.A. Morsy, W.I. Khalife
University of Texas Medical Branch, Galveston, TX, USA

OPTIMIZING HEART FAILURE OUTCOMES: WHICH HOSPITAL CARE MODEL CAN WE LEARN FROM?
P.M. Ndunda, M. Farhoud, H. Farhoud, K.J. Kallail
Kansas University School of Medicine-Wichita, Wichita, KS, USA

COMPARATIVE EFFECTIVENESS OF TRANSITIONAL CARE SERVICES IN PATIENTS DISCHARGED FROM THE HOSPITAL WITH HEART FAILURE (HF):  A META-ANALYSIS
H.G.C. Van Spall, O. Mytton, M. Coppiens, T. Shiga, B. Haynes, S. Connolly
Population Health Research Institute and McMaster University, Hamilton, Ontario, Canada

INFLUENCE OF PREHYPERTENSION AND STAGE-1 HYPERTENSION ON THE OUTCOME OF ADULTS WITH HYPERTROPHIC CARDIOMYOPATHY
Y.R. Manda, L.B. Chebrolu, J. Shirani
St Luke's University Health Network, Bethlehem, PA, USA

ASSOCIATION OF HUMANIN A NOVEL MITOCHONDRIAL DERIVED PROTEIN AND HUMAN HEART FAILURE: RESULTS OF A PILOT INVESTIGATION
H. Narayanasamy, N. Bardia, J. Wan, D. Lee, P. Cohen, L. Grazette
Keck Medical School of USC, LA, CA, USA

DECREASED RENAL FUNCTION IS ASSOCIATED WITH HEART FAILURE READMISSION
M.R. Vindhyal, B. Duran, H. Farhoud, K.J. Kallail
KU School of Medicine, Wichita, Kansas, USA

EDHFIC: INITIAL EXPERIENCE WITH A NOVEL MULTIDISCIPLINARY COLLABORATION TO DECREASE HEART FAILURE ADMISSIONS
A.S. Bhatt, C. Cosgrove, M. Moorer, A.J. Smally, J. Radojevic, D. Wencker,
J.A. Gluck
University of Connecticut School of Medicine, Farmington, CT, USA

COLCHICINE USE FOR THE PRIMARY PREVENTION OF POSTPERICARDIOTOMY SYNDROME (CUPP): A META-ANALYSIS
C.K. Fomaneg, P.E.E Samonte, M.M. Sasondoncillo-Nadal, C.L.L Sim-Apura, L.P. Padua
Philippine Heart Center, Quezon City, Philippines

TRASTUZMAB CARDIOTOXICITY DOCUMENTED BY SERIAL ASSESSMENT OF LEFT VENTRICULAR SYSTOLIC FUNCTION AND GLOBAL LONGITUDIANL PEAK STRAIN
A.M. Cook, R.C. Phillion, K.J. Babbitt, L.L. Eberhart, D.E. Langholz, H.L. Sherman. Spectrum Health Frederik Meijer Heart & Vascular Institute, Grand Rapids, MI, USA

PREDICTORS OF LEFT VENTRICULAR DYSFUNCTION AFTER ARTERIAL-VENOUS FISTULA PLACEMENT
R. Dhingra, S. Tariq, J. Anderson, M. Gallichio, M. Torosoff
Albany Medical College, Albany, NY, USA

 

MONDAY, JULY 28, 2104

_________________________________________________________________________________________

08:00 – 13:00                                                                                                   Poster Hall
_________________________________________________________________________________________

P501     MOLECULAR AND CELLULAR CARDIOLOGY, BASIC AND TRANSLATIONAL RESEARCH

ENHANCED INHIBITORY EFFECTS OF AMIODARONE ON HERG CHANNELS DUE TO A COMPOUND MUTATION L539/FS47-HERG LINKED TO LONG QT SYNDROME TYPE 2
G.L. Li, A.F. Zhang, J.E. Wu, W.Q. Han, S.T. Ma, Y. Lv, C.C. Cui, C.F. Sun
The First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, China

GAB1 IS ESSENTIAL FOR CARDIOPROTECTION AGAINST ISCHEMIC/REPERFUSION INJURY
L. Sun, C. Chen, B. Jiang, X. Yang, R.L. Zhang, Y.Q. Huo, G.S. Feng, Y. Zhang, J.C. Luo
Institute of Molecular Medicine, Peking University, Beijing, China

PREVALENCE OF ANTIPLATELET DRUG RESISTANCE IN ASIAN COMMUNITY
A.P. Sadath, G.V. Raghavan
Kims Hospital, Trivandrum, Kerala, India

ANTIOXIDANT EFFECT OF METABOLIC DRUG ELTACIN AND ITS USE IN THERAPY OF AGING PATIENTS WITH ISCHEMIC HEART DISEASE
E.V. Kalinina, R.M, Zaslavskaya, Y.R. Nartsissov
Peoples’ Friendship University of Russia, Moscow, MS, Russia

ESSENTIAL ROLE OF UVRAG IN CARDIAC FUNCTION
L. An, Z. Song, Y. Ye, Y. Zou, L. He, H. Zhu
Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China

HIGH-FAT DIET ENHANCED CTRP1 PROTEIN STIMULATES SIGNALING PATHWAY RELATED TO MUSCLE CONTRACTION IN C2C12 MYOCYTES
Y. Yang
Sookmyung Women’s University, Seoul, Republic of Korea

 

P502     PROGRESS IN ECHOCARDIOGRAPHY

IMPORTANT ETHNIC DIFFERENCES IN STROKE VOLUME (SV) – BODY SURFACE AREA (BSA) RELATIONS: ECHONORMAL META-ANALYSIS
J.M. Gardin, K.K. Poppe, G.A. Whalley; R. Senior, on behalf of the EchoNoRMAL collaborators
Hackensack University Medical Center, Hackensack, NJ, USA

ECHOCARDIOGRAPHIC INDICES ASSOCIATED WITH THE PHENOTYPE OF FRAILTY
S.M. Gharacholou, T. Tashiro, S.S. Cha, P.Y. Takahashi
Mayo Clinic Health System, La Crosse, WI, USA

ANALYSIS OF VALVAR AND LEFT VENTRICULAR PARAMETERS IN INFECTIVE AORTIC ENDOCARDITIS AS PREDICTORS OF OUTCOME: A COMBINED ASSESSMENT BY TRANSESOPHAGEAL AND STRAIN ECHOCARDIOGRAPHY
A. Vitarelli, L. Capotosto, F. Caranci, I. D'Angeli, M. De Maio, R. Ashurov
Sapienza University, Rome, Italy

ENHANCEMENT OF PEAK AORTIC VELOCITY SIGNALS BY CONTRAST MICROBUBBLES
J.C. Westerdale, E. McMahon, M. Katayama, H.P. Chaliki, M. Belohlavek
Mayo Clinic Arizona, Scottsdale, AZ, USA

ASSESSMENT OF LEFT AND RIGHT ATRIAL FUNCTION BY THREE-DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY FOLLOWING PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE
A. Vitarelli, E. Mangieri, G. Tanzilli, L. Capotosto, A. Azzano, K. Mukred, M. De Maio,
R. Ashurov
Sapienza University, Rome, Italy

RIGHT VENTRICULAR DYSFUNCTION AND DYSSYNCHRONY AFTER SURGICAL REPAIR OF TETRALOGY OF FALLOT: A THREE-DIMENSIONAL AND SPECKLE TRACKING ECHOCARDIOGRAPHIC STUDY
A. Vitarelli, F. Miraldi, I. D'Angeli, L. Capotosto, R. Ashurov, M. De Maio
Sapienza University, Rome, Italy

TWO-DIMENSIONAL AND THREE-DIMENSIONAL SPECKLE-TRACKING ECHOCARDIOGRAPHY IN THE ASSESSMENT OF LEFT AND RIGHT VENTRICULAR FUNCTION AFTER MITRACLIP IMPLANTATION IN FUNCTIONAL MITRAL REGURGITATION
A. Vitarelli, E. Mangieri, G. Tanzilli, L. Capotosto, R. Ashurov, M. De Maio
Sapienza University, Rome, Italy

CORRELATION OF LEFT ATRIAL APPENDAGE (LAA) INFLOW AND OUTFLOW VELOCITIES WITH THE CHADS2 AND CHA2DS2-VASC SCORES
C.B. Clark, N. Telles, C.H. Renner
Iowa Physicians Clinic Medical Foundation, Des Moines, Iowa, USA

ROLE OF SIMULATION IN ECHOCARDIOGRAPHY TRAINING IN CARDIOLOGY FELLOWS: A PILOT STUDY
N. Sareen, R. Adams, A. Ojha, K. Patel, W. Smith
St Joseph Mercy Oakland, Wayne State University, Pontiac, MI, USA

A META-ANALYSIS OF ASSOCIATION BETWEEN EPICARDIAL ADIPOSE TISSUE AND DIASTOLIC DYSFUNCTION
P. Agasthi, H.J. Willens, L. Tamariz
University of Miami, Miami, FL, USA

BICUSPID AORTIC VALVE AND AORTIC ROOT MORPHOLOGY IN HISPANIC PATIENTS 
S.A. Horvath, C.G. Mihos, H.M. Elmahdy, A.M. Pineda, J.P. Rodriguez-Escudero, O. Santana
Department of Internal Medicine at Mount Sinai Medical Center, Miami Beach, FL, USA

CHANGES IN LV SYSTOLIC FUNCTION AND DIMENSIONS AFTER AV FISTULA PLACEMENT
S.M. Tariq, J. Anderson, R. Dhignra, M. Gallichio, S.A Fein, M. Torosoff
Albany Medical Center, Albany, NY, USA

ANOMALOUS ORIGIN OF THE LEFT CORONARY ARTERY FROM THE PULMONARY TRUNK IN ASYMPTOMATIC ADOLESCENT ATHLETE. CASE REPORT
E. Vallejo, K. Rojas, C. Cely, D. Maldonado
Universidad Libre-seccional, Cali, Columbia

3D TRANSESOPHAGEAL ECHOCARDIOGRAPHY IMPROVES LEFT ATRIAL APPENDAGE EVALUATION PRIOR TO CARDIOVERSION
A. Ali, J. Banchs, A. Haouzi
Penn State University, Hershey, PA, USA

 

 

MONDAY, JULY 28, 2104

_________________________________________________________________________________________

08:00 – 13:00                                                                                                   Poster Hall
_________________________________________________________________________________________

P503     ATRIAL FIBRILLATION AND STROKE PREVENTION

HOW IS THE QUALITY OF INR CONTROL FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION IN CLINICAL PRAXIS?
A. Martinez-Rubio, M. Santalo-Corcoy, E. Agut-Busquet, D. Valcarcel-Paz,
M. DiazNuila-Alcazar, M. Bonet-Alvarez, R. Flores-Clotet, J.C. Oliva-Morera
University Hospital of Sabadell (Univ. Autonoma de Barcelona), Sabadell, Spain

AGE AND GENDER COMPARISONS OF ATRIAL FIBRILLATION PREVALENCE IN PATIENTS WITH HYPERTENSION AND NORMAL BLOOD PRESSURE
O.W. Odunukan, P.A. Rahman, D. Roellinger, S. Cha, J.M. Naessens, S.J. Taler, M.A. Nyman
Division of Cardiology, Mayo Clinic Jacksonville, FL, USA

ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION: A SINGLE CENTER RETROSPECTIVE STUDY
W. Xiang, M.L. Liu, F. Liu, X.R. Feng, Y.C. Wang
First Hospital, Peking University, Beijing, China

ELEVATED SERUM URIC ACID LEVELS AND DIASTOLIC DYSFUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION CONVERTED TO SINUS RHYTHM
J.O. Na, S.K. Lee, C.U. Choi, H.E. Lim, J.W. Kim, E.J. Kim, S.W. Rha, C.G. Park, H.S. Seo, D.J. Oh
Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea

ANGIOEDEMA:  AN UNCOMMON BUT POTENTIALLY LIFE-THREATENING DRUG REACTION OF APIXIBAN
A. Khan, T. Aung, R. Bhagat, D. Mascarenhas, Easton Hospital, Pennsylvania, PA, USA

HEPATITIS C PATIENTS HAVE A HIGHER RISK OF ATRIAL FIBRILLATION
H. Paydak, N.V. Pothineni, S. Vallurupalli, J.L. Mehta
University of Arkansas for Medical Sciences, Little Rock, AR, USA

OBSERVATIONAL STUDY OF THE CHARACTERISITICS AND MANAGEMENT OF PATIENTS ADMITTED WITH A PRIMARY DIAGNOSIS OF ATRIAL FIBRILLATION
Z.S. Brewer, M. Rawala, C. Velarde, M. Hamdan, R. Ali, R. Chahoud, S. Kemper,
W.H. Carter, Charleston Area Medical Center, Charleston, WV, USA

SPONTANEOUS SUBDURAL HEMATOMA WHILE ON XARELTO (RIVAROXABAN)
A. Kodali, C.A. Hadadi, F. Elmi, Easton Hospital, Easton, PA, USA

 

P504     HEART VALVE DISEASE – CAUSES, SYMPTOMS, DIAGNOSIS AND TREATMENT

PREDICTED AND OBSERVED OUTCOMES OF MINIMALLY INVASIVE SURGERY FOR NATIVE AORTIC OR MITRAL VALVE INFECTIVE ENDOCARDITIS VIA A RIGHT MINI-THORACOTOMY APPROACH
H.M. Elmahdy, S.I. Gomez, C.G. Mihos, S.A. Horvath, A.M. Pineda, O. Santana, J. Lamelas
Department of Internal Medicine at Mount Sinai Medical Center, Miami Beach, FL, USA

TRANSCUTANEOUS AORTIC VALVE REPLACEMENT UNDER FLUROSCOPIC GUIDANCE AND LOCAL ANESTHESIA ONLY
M. Greif, P. Lange, C. Schmitz, M. D´Anastasi, C. Kupatt
University of Munich, Department of Cardiology, Bayern, Germany

EFFECTS OF GENDER ON TRANSCATHETER AORTIC VALVE REPLACEMENT OUTCOMES
S. Dsouza, A. Elkharbotly, A. Delago, M. El-Hajjar, B. Shkolnik, D. Adams, A. White, M. Riordan, M. Torosoff
Albany Medical Center, Albany, NY, USA

DO EDWARD SAPIENS AND COREVALVE TRANSCATHETER DEVICES HAVE DIFFERENT PROCEDURE COMPLICATIONS FOR AORTIC VALVE REPLACEMENT?  A META-ANALYSIS
D. Garcia, M. Ansari, R. Nascimento, J. Toussaint, C. Martinez, C. Alfonso, A. Heldman
University of Miami/Jackson Memorial Hospital, Miami, FL, USA

ASSOCIATION OF AORTIC VALVE CALCIFICATION AND EPICARDIAL FAT VOLUME
R. Koos, V. Brandenburg, N. Marx, C. Kuhl, S. Reinartz, T. Dirrichs
Department of Cardiology, RWTH Aachen University, Germany

IMPACT OF POSTOPERATIVE COMPLICATIONS ON LONG-TERM SURVIVAL IN ISOLATED AORTIC VALVE REPLACEMENT
J. Rubio Alvarez, A. Granda Bauza, L. Reija Lopez, A. Narvaez, J.M. Martinez Cereijo, J. Sierra Quiroga,
C. Rubio Taboada
University Hospital Santiago de Compostela, Spain

AGE ADJUSTED MORTALITY RATE FROM AORTIC VALVE SURGERY SHOWED PERSISTENT REDUCTION IN THE IN THE UNITED STATE WITH ELIMINATION OF GENDER GAP IN RECENT YEARS
M.R. Movahed, M. Hashemzadeh, M. Hashemzadeh
CareMore Health Care Arizona, USA

OBESITY AND OUTCOMES IN NORTH-AMERICAN PATIENTS TREATED WITH TRANSCATHETER AORTIC-VALVE REPLACEMENT
M. Riordan, A. Elkharbotly, A. Delago, M. El-Hajjar, A. Padala, B. Shkolnik, S. Dsouza, M. Torosoff
Albany Medical Center, Albany, NY, USA

OUR APPROACH TO SURGERY OF THE AORTIC ROOT ABSCESS: A 15-YEARS EXPERIENCE
Y. Ozen, S. Sarikaya, O. Altas, E. Aksoy, E. Kafali, K. Kirali
Kosuyolu Heart Training and Research Hospital, Istanbul, Turkey

INCIDENCE AND PREDICTORS OF PERMANENT PACEMAKER IMPLANTATION AFTER VALVE SURGERY- A SINGLE CENTRE EXPERIENCE
B. Ayub, Y. Nawaz, H. Saif, J. Guthier, M. Weiss, T. Phillips, J. Wu, R. Singer, R. Freudenberger, R. Malacoff
Abington Memorial Hospital, Abington, PA, USA

THE OPTIMAL CHOICE OF AVR PROSTHESIS AT AGE 60- WARFARIN OR REOPERATION
S. Aranki, M. Yammine, T. Kaneko
Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

NEW LBBB FOLLOWING TRANSCATHETER SAPIEN VALVE:  INSIGHT INTO MECHANISMS
L. Jiang, G. Valania, W. Hiser, A. M. Islam
Baystate Medical Center, Tufts University, MA, USA

VALVE SPARING AORTIC ROOT RE-IMPLANTATION (DAVID V PROCEDURE): EARLY AND MIDTERMS RESULTS OF OUR CLINIC
S. Sarikaya, K. Kirali, Y. Ozen, A. Elibol, E. Basaran
Kartal Kosuyolu Heart Education and Research Hospital, Istanbul, Turkey

VALVULAR MIGRATION AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: A CASE SERIES
C. Chu
Newark Beth Israel Medical Center, Newark, NJ, USA

 

P505     PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME

THE DRIER THE BETTER: DOES RISING CREATININE FOLLOWING ULTRAFILTRATION IN ACUTE DECOMPENSATED HEART FAILURE PREDICT READMISSION?
S. Desai, S.K. Desai, R. Gerkin, A. Khurana, A. Loli
Banner Good Samaritan Medical Center, Phoenix, AZ, USA

COMPARISON OF HOSPITAL READMISSION RATES IN HEART FAILURE PATIENTS WITH REDUCED VS. PRESERVED LEFT VENTRICULAR EJECTION FRACTION
I. Abramova, E.S. Shlofmitz, J. Guo, K. Lee, W.S. Malik, K. Zalewski, C. Weinberg,
C. Keane, T.C. Kerwin
New York Hospital Queens, Weill Medical College, Flushing, NY, USA

A TEAM BASED STRATEGY TO MANAGE HIGH RISK HEART FAILURE PATIENTS IN A LARGE URBAN HEALTHCARE DELIVERY MODEL
I. Kedan, R. Khandwalla, K. Birkeland
Cedars Sinai Heart Institute, Los Angeles, CA, USA

INCIDENCE, RISK FACTORS, AND OUTCOME OF ACUTE DECOMPENSATED HEART FAILURE (ADHF) SUPERIMPOSED ACUTE EXARCERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (AECOPD)
P. Charoenpong, C. Clarke
Advocate Illinois Masonic Medical Center, Chicago, IL, USA

EFFECT OF CARE TRANSITION INTERVENTIONS ON DIFFERENT HEART FAILURE PATIENT SUBGROUPS, DEFINED BY UNDERLYING ETIOLOGY:  ARE THERE IDENTIFIABLE SUBGROUPS MORE LIKELY TO BENEFIT? 
T. Kern, I. Kedan, A. Kimchi
Cedars-Sinai Heart Institute, Los Angeles, CA, USA

IMPACT OF ECHO-GUIDED MEDICATION OPTIMIZATION IN PATIENTS WITH CHRONIC HEART FAILURE
F. Garcia Trobo, L. Pastori, B. Manduca, G. Pekler, F. Visco
New York Medical College, New York, NY, USA

FACTORS AFFECTING CARDIO-RENAL SYNDROME AND OUTCOMES IN ACUTE CONGESTIVE HEART FAILURE PATIENTS
S. Samavedam, V. Ravi, I. Pallekonda, C. Reddy, J. Awad, J. Prior
The Wright Center for Graduate Medical Education, Scranton, PA, USA